Humanized Mouse Models

Humanized mouse models are beneficial tools for immuno-oncology and infectious disease research. They have improved the ability to predict human responses to new therapeutics in clinical development.

Depending on research requirements, it is critical that researchers have the ability to obtain study-ready animals or maintain the option to humanize the mice in-house to meet their project timelines and study requirements.

Choose the Humanized Mouse Model Option
That's Best for You

humanized mouse in the hands of a researcher

When your research requires humanized animal models, Charles River offers multiple options, both founded on the NCG triple-immunodeficient mouse.*

CD34+ Humanized Mouse Model
PBMC Humanized Mouse Model
NCG/PBMC Select Humanization Kit

* Available in North America only

Advance Your Program with Humanized Mouse Models

Currently, the Charles River NCG triple-immunodeficient mouse model is the foundation for our humanization portfolio. Its unique phenotype allows it to host xenograft cells, tissue, and human immune system components. It displays noticeable improvements of foreign tissue transplantation and engraftment, compared to previous generations of immunocompromised mice.

The NCG mouse is best suited for studies on tumor biology, immuno-oncology, infectious diseases, graft-versus-host disease (GvHD), hematopoiesis, and tissue transplantation.

Mouse icon for cross linking to Discovery Services

Charles River's expertise in oncology drug discovery, spanning from target identification to IND studies, makes us ideally suited to run your humanized mouse tumor model studies for you.

Charles River Hu-Mouse™ Models

We now have two options available for humanized mouse models, engrafted with either PBMC or CD34+ stem cells derived from umbilical cord blood. These models have been shown to respond to known immune checkpoint inhibitor therapies.

HSC derived from umbilical cord; multiple donors in each cohort. A single cohort of animals can engraft with a single donor.
~Week 15: > 25% huCD45 blood cells Week 3: ~30% huCD45 blood cells
T cell focused T cell focused
Long-term studies (no GvHD) Short-term studies due to GvHD
Number of T cells may vary with multiple donors GvHD onset varies with donor
  Less costly approach

The ability of human immune cells to engraft in the NCG mouse makes it a powerful tool to evaluate compounds for immuno-oncology, GvHD, infectious diseases, and inflammatory diseases.

Are humanized mice the emerging model
to evaluate immune checkpoint therapeutics?

Choose the option that's best for you:*

* Available in North America only

Frequently Asked Questions (FAQs) About Humanized Mice